标题：Author Correction: Glucose and fatty acid metabolism involved in the protective effect of metformin against ulipristal-induced endometrial changes in rats
摘要：Correction to:
Scientific Reports 10.1038/s41598-021-88346-w, published online 23 April 2021
In the original version of the Article, Figure 4 was a duplication of Figure 3.
The original Figure
4 and accompanying legend appear below.
Figure 4
Effect of metformin or/and ulipristal on the expression of the proliferation markers of rats’ uteri. (
A–
D) photomicrographs of uteri shows expression of PCNA (
A) Uterine wall in the control group. (
B) Uterine wall in ulipristal treated group. (
C) Uterine wall in metformin treated group. (
D) Uterine wall in the ulipristal and metformin treated group. × 400 magnification (scale bar = 20 μm). (
E) Expression quantification of the optical density reactivity of positive cells of PCNA by the ImageJ analysis system. (
F) Quantitative RT-PCR analysis of PCNA mRNA expression. (
G–
J) Photomicrographs of uteri shows expression of Cyclin-D. (
G) Uterine wall in the control group. (
H) Uterine wall in ulipristal treated group. (I) Uterine wall in metformin treated group. (
J) Uterine wall in the ulipristal and metformin treated group. × 400 magnification (scale bar = 20 μm). (
K) Expression quantification of the optical density reactivity of positive cells by the ImageJ analysis system. (
L) Quantitative RT-PCR analysis of Cyclin D1 mRNA expression, Black arrow refers to reactivity in endometrial glands, red arrows refers to reactivity in stromal cells. Data in figures (
E) and (
K) is represented by mean ± SD (n = 7). All value of RT-PCR is expressed as the change in cycle threshold (ΔCt). Each dot represents mean of each group (n = 7, triplicate for each rat). Negative control (DEPC-treated water) showed no detectable fluorescent signals. a or b, Statistically significant from the control or ulipristal and metformin treated group respectively at
P < 0.05 using one-way ANOVA followed by Tukey as a post hoc test.
UPA ulipristal,
MET metformin,
UPA +
MET co-treatment with ulipristal and metformin.
The original Article has been corrected.
